Latham & Watkins LLP represented the underwriters in the offering. Longboard Pharmaceuticals, Inc. closed its initial public offering of 5 million shares of its common stock at...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here